Sanara MedTech, Inc. (SMTI)
35.10
+0.03
(+0.09%)
USD |
NASDAQ |
Oct 12, 13:01
Sanara MedTech Net Income (Quarterly) : -0.4111M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4111M |
| March 31, 2026 | 0.3977M |
| December 31, 2025 | -1.107M |
| September 30, 2025 | 0.8345M |
| June 30, 2025 | 0.5003M |
| March 31, 2025 | -0.6206M |
| December 31, 2024 | 0.9347M |
| September 30, 2024 | -2.883M |
| June 30, 2024 | -3.529M |
| March 31, 2024 | -1.799M |
| December 31, 2023 | -0.2624M |
| September 30, 2023 | -1.095M |
| June 30, 2023 | -1.866M |
| March 31, 2023 | -1.216M |
| December 31, 2022 | -4.164M |
| September 30, 2022 | -1.529M |
| June 30, 2022 | 0.7569M |
| March 31, 2022 | -3.156M |
| December 31, 2021 | -3.557M |
| September 30, 2021 | -2.048M |
| June 30, 2021 | -1.206M |
| March 31, 2021 | -1.183M |
| December 31, 2020 | -0.2665M |
| September 30, 2020 | -1.208M |
| June 30, 2020 | -1.130M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.841M |
| December 31, 2019 | -1.478M |
| September 30, 2019 | -0.8432M |
| June 30, 2019 | -0.3525M |
| March 31, 2019 | -0.1626M |
| December 31, 2018 | 0.0869M |
| September 30, 2018 | 0.0512M |
| June 30, 2018 | 0.0312M |
| March 31, 2018 | 0.0062M |
| December 31, 2017 | 0.2478M |
| September 30, 2017 | -0.0486M |
| June 30, 2017 | 0.079M |
| March 31, 2017 | 0.0531M |
| December 31, 2016 | 0.2349M |
| September 30, 2016 | 0.1815M |
| June 30, 2016 | -0.9224M |
| March 31, 2016 | 0.0903M |
| December 31, 2015 | -0.446M |
| September 30, 2015 | -0.1787M |
| June 30, 2015 | -0.5823M |
| March 31, 2015 | -0.1334M |
| December 31, 2014 | -0.2853M |
| September 30, 2014 | -0.671M |
| June 30, 2014 | -0.7759M |
| March 31, 2014 | -0.546M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Intelligent Bio Solutions, Inc. | -3.917M |
| Anteris Technologies Global Corp. | -28.78M |
| 20/20 Biolabs, Inc. | -1.506M |
| Quest Diagnostics, Inc. | 333.00M |
| Labcorp Holdings, Inc. | 299.10M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 28.14M |
| Total Expenses (Quarterly) | 28.55M |
| EPS Diluted (Quarterly) | -0.0523 |
| Enterprise Value | 355.51M |
| Gross Profit Margin (Quarterly) | 90.76% |
| Profit Margin (Quarterly) | -1.46% |
| Earnings Yield | -10.56% |
| Operating Earnings Yield | 3.73% |
| Normalized Earnings Yield | -9.870 |